Ledger.Open graph →
SEC Form D · filed August 2, 2017

Rodeo Therapeutics Corp

Offering
$5.9M
Sold
$5.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SEATTLE, WA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Josuhe Leonardo Estrada Alanis · SEATTLE, WADirectorChuck Stonecipher · SEATTLE, WADirectorTadataka Yamada · Seattle, WADirectorGregory Gottesman · SEATTLE, WAExec · PromoterNicole Ramroop · Grand Cayman, Cayman IslandsDirectorLarry Thornton · Sioux Falls, SDExec · Director · PromoterFrancisco Fabricio Mendoza Ramirez · SEATTLE, WADirectorJames Sullivan · New York, NYDirectorJacob (Kobi) R. Vortman, Phd · Tirat Carmel, L3Exec · Director · PromoterEyal R. Zadicario, Phd · Tirat Carmel, L3DirectorNadir R. Alikacem, Phd · Tirat Carmel, L3Exec · PromoterFrederic H. Moll · Tirat Carmel, L3DirectorMichael H. Stansky · Tirat Carmel, L3DirectorArjun (Jj) H. Desai, Md · Tirat Carmel, L3DirectorJian Y. Gao · Hong Kong, Hong KongDirectorJames Sullivan · Berkshire, United KingdomDirectorLindsay Rayle · Seattle, WAExec · Promoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗